医療機器の提供会社STERIS plcの株式を63.4%増えた. Y Intercept Hong Kong Ltd increased its stake in medical equipment provider STERIS plc by 63.4%.

医療機器の提供会社STERIS plcの株式を調整した.Y Intercept Hong Kong Ltdを含む機関投資家は,Y Interceptの株式を63.4%増えた. Institutional investors, including Y Intercept Hong Kong Ltd, have adjusted their stakes in medical equipment provider STERIS plc, with Y Intercept increasing its holdings by 63.4%. 予想外利益の見込みはわずかですが,STERISは"中等な買い"の評価と258.75ドルの目標価格を持っています. Despite slightly missing earnings expectations, STERIS has a "Moderate Buy" rating and a $258.75 price target. 219.9億ドルの価値を持つ同社は,ヘルスケア,応用性滅菌技術,生命科学,歯科など4つのセグメントを通じて感染予防製品を提供しています. The company, valued at $21.99 billion, provides infection prevention products through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental.